Kalderos Company Profile

Background

Founded in 2016 and headquartered in Chicago, Illinois, Kalderos is a data infrastructure and analytics company specializing in drug discount management solutions. The company's mission is to enhance transparency and trust within the U.S. healthcare system by addressing inefficiencies in drug discount programs. Kalderos has developed the world's first Drug Discount Management platform, aiming to reduce non-compliance and ensure that drug discounts effectively reach the intended patients.

Key Strategic Focus

Kalderos concentrates on:

Drug Discount Management: Providing solutions that identify, monitor, and resolve non-compliance in drug discount programs, including the 340B Program and Medicaid Drug Rebate Program.

Technological Innovation: Utilizing advanced data models and machine learning to detect inconsistencies and streamline compliance processes.

Market Expansion: Extending services to support various stakeholders, including drug manufacturers, healthcare providers, payers, and government agencies, to foster collaboration and efficiency.

Financials and Funding

Kalderos has secured significant funding to support its growth:

Series A Funding (May 2019): Raised $7 million, led by Mercato Partners.

Series B Funding (June 2020): Secured $28 million, with contributions from Bain Capital Ventures and Mercato Partners.

Total Funding: Approximately $35 million over two rounds.

The capital has been utilized to expand platform capabilities, develop point-of-sale solutions, and explore additional areas in healthcare financial exchanges.

Technological Platform and Innovation

Kalderos' platform is distinguished by:

Proprietary Technologies: A SaaS-based solution that offers real-time compliance monitoring, automated discount reconciliation, and advanced analytics to identify non-compliance risks.

Scientific Methodologies: Employing sophisticated data models and machine learning algorithms to detect inconsistencies overlooked by traditional methods, thereby eliminating waste and improving efficiency.

Leadership Team

Angie Franks, Chief Executive Officer: Appointed in September 2023, Franks brings over 30 years of experience in healthcare leadership, including roles as CEO of ABOUT Healthcare and Healthland.

Tim Brown, Chief Operating Officer: Joined in January 2024, Brown has over 25 years of experience in sales and operational leadership within the pharmaceutical and healthcare technology sectors.

Kate Flathers, Head of Product: Appointed in January 2024, Flathers has 25 years of experience in product management and development, focusing on healthcare technology solutions.

Leadership Changes

CEO Transition: In September 2023, Angie Franks succeeded founder Jeremy Docken as CEO.

Executive Appointments: In January 2024, Tim Brown and Kate Flathers joined as Chief Operating Officer and Head of Product, respectively.

Competitor Profile

Market Insights and Dynamics

The drug discount management sector is experiencing growth due to increasing regulatory scrutiny and the complexity of compliance requirements. The market is characterized by a demand for innovative solutions that enhance transparency and efficiency in managing drug discounts.

Competitor Analysis

Key competitors include:

Truveris: Offers platforms for managing pharmacy benefits and drug pricing, focusing on optimizing drug discount programs.

Rebate Management Systems: Provides solutions for managing drug rebates and discounts, assisting healthcare organizations in tracking and optimizing rebate programs.

Model N: Delivers revenue and compliance management solutions for the life sciences industry, including drug pricing and discount management.

Prognos: Specializes in healthcare analytics, offering platforms for analyzing healthcare data to improve patient outcomes, indirectly competing in the drug discount management space.

Kalderos differentiates itself through its comprehensive approach to identifying and resolving non-compliance issues, user-friendly interface, and commitment to customer service.

Strategic Collaborations and Partnerships

Kalderos has established partnerships with over 100 healthcare providers and 50 payers since 2021. Notably, a collaboration with a large insurance company is projected to save $35 million in drug costs over five years.

Operational Insights

Kalderos' competitive advantages include advanced technology, a comprehensive solution covering all aspects of drug discount management, industry expertise, scalability, and cost-effectiveness. These factors contribute to its strong market position and ability to meet the evolving needs of the healthcare industry.

Strategic Opportunities and Future Directions

Kalderos aims to expand its market presence by entering international markets facing similar drug discount challenges. The company plans to invest in research and development to enhance its platform's capabilities and form strategic partnerships to offer more comprehensive solutions. Aligning with industry trends such as value-based care and data analytics, Kalderos is well-positioned for sustained growth and innovation.